S3 Investment Company Subsidiary SINO UJE Receives Distribution Rights To Medical Diagnostic Testing Products In China Market

TEMECULA, CA--(MARKET WIRE)--Jul 19, 2006 -- S3 Investment Company, Inc. (OTC BB:SEIH.OB - News) today announced that subsidiary SINO UJE, Ltd. has been awarded distribution rights in China to the HandiLab line of medical diagnostic tests from Zonda Incorporated, a California-based company. The HandiLab line of tests includes innovative, rapid, self-contained diagnostic devices for the detection of chlamydia, gonorrhea, yeast (Candida albicans) and group A Strep.
MORE ON THIS TOPIC